Jessica Tassan
Stock Analyst at Piper Sandler
(0.81)
# 3,835
Out of 4,457 analysts
220
Total ratings
45.2%
Success rate
-1.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jessica Tassan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CTEV Claritev | Maintained: Buy | $90 → $61 | $33.82 | +80.37% | 10 | Jun 3, 2026 | |
| PHR Phreesia | Downgraded: Hold | $34 → $12 | $10.29 | +16.62% | 16 | May 28, 2026 | |
| DOCS Doximity | Reiterated: Buy | $42 | $20.59 | +103.98% | 13 | May 14, 2026 | |
| HUM Humana | Maintained: Hold | $272 → $254 | $388.90 | -34.69% | 7 | May 13, 2026 | |
| HCAT Health Catalyst | Reiterated: Hold | $4 → $2 | $1.96 | +2.04% | 17 | May 12, 2026 | |
| PRVA Privia Health Group | Reiterated: Buy | $36 | $25.55 | +40.90% | 11 | May 8, 2026 | |
| HNGE Hinge Health | Maintained: Buy | $60 → $95 | $81.48 | +16.59% | 6 | May 6, 2026 | |
| UNH UnitedHealth Group | Maintained: Buy | $390 → $420 | $419.82 | +0.04% | 19 | Apr 22, 2026 | |
| CVS CVS Health | Rated: Buy | $101 → $99 | $103.58 | -4.42% | 11 | Mar 31, 2026 | |
| CI The Cigna Group | Reiterated: Buy | $374 → $370 | $278.74 | +32.74% | 6 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $23.26 | +28.98% | 14 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $9 | $8.69 | +3.57% | 22 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 | $40.92 | +19.75% | 21 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $13 → $25 | $29.45 | -15.11% | 8 | Nov 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $5.77 | +211.96% | 22 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $8 | $9.30 | n/a | 13 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 → $10 | $5.00 | n/a | 4 | Jan 17, 2024 |
Claritev
Jun 3, 2026
Maintained: Buy
Price Target: $90 → $61
Current: $33.82
Upside: +80.37%
Phreesia
May 28, 2026
Downgraded: Hold
Price Target: $34 → $12
Current: $10.29
Upside: +16.62%
Doximity
May 14, 2026
Reiterated: Buy
Price Target: $42
Current: $20.59
Upside: +103.98%
Humana
May 13, 2026
Maintained: Hold
Price Target: $272 → $254
Current: $388.90
Upside: -34.69%
Health Catalyst
May 12, 2026
Reiterated: Hold
Price Target: $4 → $2
Current: $1.96
Upside: +2.04%
Privia Health Group
May 8, 2026
Reiterated: Buy
Price Target: $36
Current: $25.55
Upside: +40.90%
Hinge Health
May 6, 2026
Maintained: Buy
Price Target: $60 → $95
Current: $81.48
Upside: +16.59%
UnitedHealth Group
Apr 22, 2026
Maintained: Buy
Price Target: $390 → $420
Current: $419.82
Upside: +0.04%
CVS Health
Mar 31, 2026
Rated: Buy
Price Target: $101 → $99
Current: $103.58
Upside: -4.42%
The Cigna Group
Mar 3, 2026
Reiterated: Buy
Price Target: $374 → $370
Current: $278.74
Upside: +32.74%
Mar 2, 2026
Reiterated: Buy
Price Target: $30
Current: $23.26
Upside: +28.98%
Feb 26, 2026
Reiterated: Buy
Price Target: $12 → $9
Current: $8.69
Upside: +3.57%
Feb 23, 2026
Reiterated: Buy
Price Target: $49
Current: $40.92
Upside: +19.75%
Nov 26, 2025
Upgraded: Buy
Price Target: $13 → $25
Current: $29.45
Upside: -15.11%
Sep 5, 2025
Reiterated: Buy
Price Target: $18
Current: $5.77
Upside: +211.96%
May 23, 2025
Reiterated: Hold
Price Target: $10 → $8
Current: $9.30
Upside: n/a
Jan 17, 2024
Maintained: Hold
Price Target: $13 → $10
Current: $5.00
Upside: n/a